Clinical trials
Recruiting Cardiovascular Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
581 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 6 |
| 2015 | 9 |
| 2016 | 7 |
| 2017 | 6 |
| 2018 | 8 |
| 2019 | 16 |
| 2020 | 19 |
| 2021 | 31 |
| 2022 | 41 |
| 2023 | 67 |
| 2024 | 116 |
| 2025 | 138 |
| 2026 | 95 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 581 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| VA Office of Research and Development | 8 |
| National Heart, Lung, and Blood Institute (NHLBI) | 7 |
| University of Alabama at Birmingham | 7 |
| Karolinska Institutet | 6 |
| Mayo Clinic | 6 |
| The Cleveland Clinic | 6 |
| University of California, San Francisco | 6 |
| National Heart Centre Singapore | 5 |
| University of Aarhus | 5 |
| University of Alberta | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 581 |
| Hypertension | 71 |
| Heart Diseases | 47 |
| Diabetes Mellitus, Type 2 | 46 |
| Obesity | 46 |
| Heart Failure | 45 |
| Diabetes Mellitus | 37 |
| Vascular Diseases | 33 |
| Atherosclerosis | 32 |
| Coronary Artery Disease | 31 |
Trials
Showing 26 to 50 of 581. Each trial links to its page on Pharma Observatory.
481 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.